|
PIGK expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.22044604925031E-16 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62703184258817E-12 |
| Normal-vs-Stage2 |
1.92019999900594E-08 |
| Normal-vs-Stage3 |
2.55129251058861E-13 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
7.679200E-01 |
| Stage1-vs-Stage3 |
3.176400E-01 |
| Stage1-vs-Stage4 |
2.185800E-02 |
| Stage2-vs-Stage3 |
3.923000E-01 |
| Stage2-vs-Stage4 |
1.676200E-01 |
| Stage3-vs-Stage4 |
5.375000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62458935193399E-12 |
| Normal-vs-AfricanAmerican |
1.62447832963153E-12 |
| Normal-vs-Asian |
5.762700E-03 |
| Caucasian-vs-AfricanAmerican |
2.671700E-02 |
| Caucasian-vs-Asian |
5.963400E-01 |
| AfricanAmerican-vs-Asian |
1.258050E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.11022302462516E-16 |
| Male-vs-Female |
4.899600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.01136893199327E-12 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
1.62899693734175E-11 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.631000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.108800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.798200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.292400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.579400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.833170E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.646770E-04 |
| Normal-vs-Grade 2 |
5.11812814352197E-13 |
| Normal-vs-Grade 3 |
1.62447832963153E-12 |
| Normal-vs-Grade 4 |
1.62447832963153E-12 |
| Grade 1-vs-Grade 2 |
9.835800E-01 |
| Grade 1-vs-Grade 3 |
2.158800E-01 |
| Grade 1-vs-Grade 4 |
5.786000E-02 |
| Grade 2-vs-Grade 3 |
1.163580E-02 |
| Grade 2-vs-Grade 4 |
5.372200E-04 |
| Grade 3-vs-Grade 4 |
6.446300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62436730732907E-12 |
| Normal-vs-ccB subtype |
1.63247193540883E-12 |
| ccA subtype-vs-ccB subtype |
1.987810E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.6286971771251E-12 |
| Normal-vs-N1 |
3.3774999996794E-07 |
| N0-vs-N1 |
3.240800E-01 |
|
|
